25.31
0.04%
0.010
Handel nachbörslich:
25.38
0.07
+0.28%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Lifevantage Corporation Aktie (LFVN) Neueste Nachrichten
LifeVantage Corporation (Nasdaq: LFVN) Reports Preliminary Q2 FY2025 Revenue Growth and Raises Full-Year Guidance – Market - HPBL
LifeVantage Corporation (NASDAQ: LFVN) Performance Overview – Market - HPBL
Ritholtz Wealth Management Buys 18,682 Shares of LifeVantage Co. (NASDAQ:LFVN) - MarketBeat
Short Interest in LifeVantage Co. (NASDAQ:LFVN) Drops By 5.4% - MarketBeat
LifeVantage Corporation Reports Preliminary Q2 Fiscal 2025 Results and Raises Revenue Guidance - HPBL
LifeVantage Corporation Raises FY 2025 Revenue Guidance – Market - HPBL
Barclays PLC Raises Stock Holdings in LifeVantage Co. (NASDAQ:LFVN) - MarketBeat
LifeVantage Soars on Strong FQ2 Guidance and Robust Product Demand – Market - HPBL
LifeVantage welcomes Todd Thompson as chief information and innovation officer - Utah Business
Todd Thompson - Direct Selling News
LifeVantage appoints new Chief Information and Innovation Officer - Investing.com
LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer - GlobeNewswire
LifeVantage Appoints Former JetBlue, Starwood Hotels CIO Todd Thompson to Lead Innovation - StockTitan
Craig-Hallum sets price target for Lifevantage stock with buy rating - Investing.com Australia
Lifevantage Corp (LFVN) Stock Price Up 8.52% on Jan 14 - GuruFocus.com
LifeVantage expands health product suite, plans global rollout By Investing.com - Investing.com Australia
LifeVantage (NASDAQ:LFVN) Coverage Initiated by Analysts at Craig Hallum - MarketBeat
LifeVantage announces results of third-party cell study of health weight stack - Yahoo Finance
LifeVantage Corporation: 2QFY25 Sales Upside Pre-Announced; Raising Estimates - Smartkarma
LifeVantage Unveils 2025 Vision - Direct Selling News
LifeVantage reports cellular health study results By Investing.com - Investing.com South Africa
LifeVantage reports cellular health study results - Investing.com India
LifeVantage expands health product suite, plans global rollout - Investing.com India
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack* - GlobeNewswire
LifeVantage Launches 2025 Vision with “Drive ERA” Theme and - GlobeNewswire
LifeVantage Expands MindBody GLP-1 System Globally, New Study Shows Enhanced Benefits - StockTitan
LifeVantage Study: Healthy Weight Stack Activates 22 New Genes for Enhanced Organ Health - StockTitan
Undercovered Dozen: Fannie Mae, Civitas Resources, LifeVantage, ZenaTech + - Seeking Alpha
Uncovering LifeVantage And Two Promising Small Caps In The US - Yahoo Finance
LifeVantage: Bold Move Into The GLP-1 Weight Loss Market Turns Out To Be A Major WinnerBuy - Seeking Alpha
LifeVantage Corporation's (NASDAQ:LFVN) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Simply Wall St
LifeVantage stock soars to 52-week high, hits $22.25 By Investing.com - Investing.com Nigeria
LifeVantage soars after seeing a sales boost from its GLP-1 product - MSN
LifeVantage Corporation Raises Revenue Guidance for the Fiscal Year 2025 - Marketscreener.com
LifeVantage soars after seeing a sales boost from its GLP-1 product (LFVN:NASDAQ) - Seeking Alpha
LifeVantage stock soars to 52-week high, hits $22.25 - Investing.com
LifeVantage expects Q2 revenue of about $67.5M, raises FY25 sales guidance - MSN
When the Price of (LFVN) Talks, People Listen - Stock Traders Daily
LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance - The Manila Times
LifeVantage to Participate in the 27th Annual ICR Conference - GlobeNewswire
LifeVantage Leadership to Present Growth Strategy at ICR Conference 2025 - StockTitan
Has LifeVantage Corporation's (NASDAQ:LFVN) Impressive Stock Performance Got Anything to Do With Its Fundamentals? - Yahoo Finance
(LFVN) Technical Data - Stock Traders Daily
LifeVantage stock soars to 52-week high, hits $18.43 By Investing.com - Investing.com Canada
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):